TAF (tenofovir alafenamide)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for TAF (tenofovir alafenamide), covering 2024-07-15 to 2024-11-12. Get the full timeline:
Most recent: Clinical Trial Update: TAF to Prevent HBV Reactivation in Cancer Patients [Phase 4]